Fisher buys BioServices in $60M deal

McKesson is selling Rockville, Maryland-based BioServices -- a clinical-trial supply business -- to Fisher Scientific for $60 million. The operation has about $50 million in annual sales in biological specimens and trial materials.

- read this story from the San Francisco Business Times

Suggested Articles

Californian RNA biotech Arrowhead will lose its COO and R&D head from next year but is hiring a new CMO and CSO to help steady its research exec team.

The biotech began testing the small molecule in a phase 3 trial of heavily pretreated small cell lung cancer patients late last year. 

Roche is spending up to $1.4 billion to snap up a scarring-focused biotech, nabbing an FDA breakthrough-tagged therapy in the process.